These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10588626)

  • 21. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
    Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
    Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Pseudomonas aeruginosa endobronchitis in rhesus monkeys: I. Effects of pentoxifylline on neutrophil influx.
    Cheung AT; Moss RB; Leong AB; Novick WJ
    J Med Primatol; 1992; 21(7-8):357-62. PubMed ID: 1307753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Konstan MW; Hilliard KA; Norvell TM; Berger M
    Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
    Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
    J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection.
    Bayes HK; Ritchie N; Irvine S; Evans TJ
    Sci Rep; 2016 Nov; 6():35838. PubMed ID: 27804985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.
    Guilbault C; Stotland P; Lachance C; Tam M; Keller A; Thompson-Snipes L; Cowley E; Hamilton TA; Eidelman DH; Stevenson MM; Radzioch D
    Immunology; 2002 Nov; 107(3):297-305. PubMed ID: 12423305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
    Cantin AM; Woods DE
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1130-5. PubMed ID: 10508798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
    Dosanjh AK; Elashoff D; Robbins RC
    J Interferon Cytokine Res; 1998 Oct; 18(10):851-4. PubMed ID: 9809620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.
    Schwartz DA; Quinn TJ; Thorne PS; Sayeed S; Yi AK; Krieg AM
    J Clin Invest; 1997 Jul; 100(1):68-73. PubMed ID: 9202058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.
    Kasetty G; Papareddy P; Bhongir RK; Egesten A
    J Pharmacol Exp Ther; 2016 Apr; 357(1):66-72. PubMed ID: 26865680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients.
    Muhlebach MS; Stewart PW; Leigh MW; Noah TL
    Am J Respir Crit Care Med; 1999 Jul; 160(1):186-91. PubMed ID: 10390398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
    Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
    Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
    Wang Y; Cela E; Gagnon S; Sweezey NB
    Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of
    Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S
    Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pressurized whey protein can limit bacterial burden and protein oxidation in Pseudomonas aeruginosa lung infection.
    Kishta OA; Iskandar M; Dauletbaev N; Kubow S; Lands LC
    Nutrition; 2013 Jun; 29(6):918-24. PubMed ID: 23395602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
    Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
    Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential diaphragmatic weakness during sustained Pseudomonas aeruginosa lung infection.
    Divangahi M; Matecki S; Dudley RW; Tuck SA; Bao W; Radzioch D; Comtois AS; Petrof BJ
    Am J Respir Crit Care Med; 2004 Mar; 169(6):679-86. PubMed ID: 14670804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.